Current level of inflation is at an all-time high, which presents a window of opportunity for CDMOs to make investments in possibly more cost-effective choices.
Over the next four years, the Food and Drug Administration will allocate $38 million to promote research into uncommon disorders like amyotrophic lateral sclerosis.
Based on the lessons learned from the COVID-19 outbreak,outsourcing oral solids production will have a huge impact on contract manufacturing in ten years.
The constraints that COVID-19 imposed on participation in other disease areas have had a consequence on the environment of clinical trial research in Britain.
India has 3 ministries that control biotech sector, and regulatory processes are slowed down by ineffective coordination among ministries and needless stages.
